Free shipping on orders over $150
IGF-1 LR3
Growth

IGF-1 LR3

Long-Arg3 insulin-like growth factor 1 — a 83-amino acid recombinant variant engineered for extended half-life and reduced IGF binding protein affinity. Studied in anabolism, muscle protein synthesis, and satellite cell research.

$84.99
≥99% Purity
Free 2-Day Shipping
Secure Ordering
COA Every Order
Third Party Tested
Lot Tracking
Purity≥98.0% HPLC
MW9,117 g/mol
Sequence83 amino acids (Arg3 substitution + 13-aa N-terminal extension)
CAS946870-92-4
Storage−80°C or −20°C, desiccated, avoid freeze-thaw

For laboratory and in vitro research purposes only. Not for human consumption.

What is IGF-1 LR3?

IGF-1 LR3 is an engineered variant of insulin-like growth factor 1 (IGF-1) with two structural modifications: an arginine substitution at position 3 that reduces binding to IGF binding proteins (IGFBPs) by approximately 500-fold, and a 13-amino acid N-terminal extension that extends its plasma half-life to 20–30 hours. These modifications make it significantly more bioavailable at the receptor level than native IGF-1, and more practical for preclinical experimental designs requiring sustained IGF-1 signalling. It is a standard research tool in cell biology and muscle physiology labs.

IGF-1 LR3

20-30 hour half-life.
500x less binding protein.

Two modifications distinguish IGF-1 LR3 from native IGF-1: the Arg3 substitution reduces IGFBP binding 500-fold, dramatically increasing bioavailability. The 13-amino acid extension extends half-life from hours to roughly a day. For research requiring sustained IGF-1 signalling, this is the standard tool.

20–30× longer half-life than native IGF-1
≥98.0% HPLC purity verified
MS mass spec confirmed

How IGF-1 LR3 works in research models

IGF-1 LR3 is an engineered analogue of native IGF-1 with two structural modifications that reduce binding to IGFBPs (~500-fold) and extend plasma half-life to approximately 20–30 hours. It activates the IGF-1R receptor, initiating PI3K/Akt/mTOR and MAPK signalling — pathways central to cell proliferation, protein synthesis, glucose uptake, and satellite cell activation in skeletal muscle research.

IGF-1R Activation
mTOR/PI3K Signalling
Satellite Cell Activation
Extended Half-Life
IGF-1 LR3

mtor and pi3k.
studied in muscle and cell research.

IGF-1 LR3 activates the IGF-1 receptor, initiating PI3K/Akt/mTOR and MAPK signalling — pathways central to cell proliferation, protein synthesis, and satellite cell activation in skeletal muscle research. A standard reagent in cell biology labs worldwide.

Francis GL, et al.

Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form.

Biochem J · 1988 · PMID: 3048536

Tomas FM, et al.

Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats.

Biochem J · 1992 · PMID: 1329962

In vitro cell culture research typically uses IGF-1 LR3 at 1–100 ng/mL. In vivo rodent studies use 10–100 mcg/kg doses. Reconstitute in acidified sterile water or acetic acid solution. Stable at −80°C long-term; avoid repeated freeze-thaw cycles.

CompoundIGF-1 LR3
LotRP-2026-001
HPLC Purity≥98.0% HPLC
Mass SpecConfirmed
Endotoxin<1 EU/mg
LabJanoshik Analytical
StatusReleased
View Testing Process
Questions & Answers

You ask, we answer.

The LR3 modifications reduce binding to IGFBPs by approximately 500-fold. Since IGFBPs sequester native IGF-1, LR3 has dramatically more bioavailable hormone at the receptor level, and its extended half-life (~20–30h vs ~12h) makes it more practical for preclinical experimental designs.

No. MGF (mechano growth factor) is an IGF-1 splice variant produced locally in muscle tissue in response to mechanical stress. IGF-1 LR3 is a synthetic, systemically circulating analogue engineered for extended half-life and IGFBP resistance.

IGF-1 LR3 binds the IGF-1 receptor (IGF-1R) and activates two primary downstream pathways: PI3K/Akt/mTOR (which drives protein synthesis, cell growth, and glucose uptake) and the MAPK/ERK pathway (which drives cell proliferation and differentiation). In skeletal muscle research, it is used to study satellite cell activation and muscle protein synthesis.

IGF-1 LR3 is more sensitive to degradation than smaller peptides. For long-term storage, −80°C is preferred. −20°C is acceptable for shorter periods. The lyophilized form is more stable than reconstituted solution. Avoid repeated freeze-thaw cycles once reconstituted.

Research Use Only

All Rowan Peptides products are intended strictly for laboratory and in vitro research purposes. They are not approved by the FDA and are not intended for human consumption, veterinary use, or any therapeutic application. By purchasing, you agree to our Terms of Service and Indemnity Waiver. Rowan Peptides LLC operates as a chemical supplier only.

5.0
Based on 3 reviews
Write a Review
Verified Purchase

Strong sourcing on this one. The long-acting modification means any impurity compounds over time so purity matters more here than most peptides. Rowan delivers. On my third vial.

Tyler J. Mar 2026
Verified Purchase

Research grade is the only grade for this compound. Rowan understands that. The IGF-1 LR3 arrived well protected, within spec, and the documentation was there.

Derek M. Feb 2026
Verified Purchase

IGF-1 LR3 is the kind of compound where you absolutely cannot compromise on sourcing. 1mg vial from Rowan, Janoshik COA in the box at 99.0%. Clean lyophilization, dissolved properly. This is the one I was most nervous about ordering from a new brand and they cleared the bar.

Marcus T. Jan 2026

Write a Review